Correction: Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study.
[This corrects the article DOI: 10.1371/journal.pone.0312912.].
Saved in:
| Main Authors: | Tuba Saygın Avşar, Louise Jackson, Pelham Barton, Sophie Beese, Hoong S Lim, David Quinn, Malcolm Price, David J Moore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0321324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conservative Management of LVAD-Associated Ventricular Pseudoaneurysm
by: Marvin Kajy, et al.
Published: (2024-01-01) -
Rezafungin for suppressive therapy of Candida auris in a patient with a left ventricular assist device (LVAD)
by: Matthew A. Stack, et al.
Published: (2025-01-01) -
Potential for health economics to influence policies on tobacco use during pregnancy in low-income and middle-income countries: a qualitative case study
by: Louise Jackson, et al.
Published: (2021-12-01) -
The burden of left ventricular assist device (LVAD) infections on costs, lengths of stay, antimicrobial consumption and resistance: a prospective case control approach
by: Matthew Ficinski, et al.
Published: (2024-12-01) -
Right-sided heart reperfusion (“Berlin bridge technique”) for right ventricle support during left ventricular assist device (LVAD) implantationCentral Message
by: Joao Roberto Breda, MD, PhD, et al.
Published: (2022-06-01)